Unknown

Dataset Information

0

Circulating Proprotein Convertase Subtilisin/Kexin type 9 level independently predicts incident cardiovascular events and all-cause mortality in hemodialysis black Africans patients.


ABSTRACT:

Background

Cardiovascular (CV) disease is the leading cause of mortality in patients with end-stage kidney disease (ESKD). The aim of the present study was to determine whether Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9) could be an independent predictor of CV events and all-cause mortality in black African haemodialysis patients.

Methods

We carried out a prospective cohort study of all consecutive hemodialysis (HD) patients between August 2016 and July 2020, admitted in six hemodialysis centers of Kinshasa, Democratic Republic of Congo. Independent determinants of plasma PCSK-9 measured by ELISA were sought using multiple linear regression analysis. Kaplan-Meier's method described the incidence of CV events while competitive and proportional risk models looked for independent risk factors for death at the .05 significance level.

Results

Out of 207 HD patients, 91 (43.9%) died; 116 (56.1%) have survived. PCSK9 level was significantly higher in deceased patients compared to survivors: 28.0 (24.0-31.0) ng/l vs 9.6 (8.6-11.6) ng/ml (p <  0.001). Patients with plasma PCSK9 levels in tertile 3 had a higher incidence of CV events and mortality compared to patients with plasma PCSK9 levels in tertile 2 or tertile 1 (p <  0.001). Tertile 3 negatively influence survival rates (26.6%) compared to tertile 2 (54.7%) and tertile 1 (85.3%). Patients in tertile 3 and tertile 2 had a 4-fold higher risk of death than patients in tertile 1. After adjustment for all parameters, competitive risk analysis showed that mortality was 2 times higher in patients with stroke. Similarly, serum albumin < 3.5 g/dL or PCSK9 in tertile 3 were respectively associated with 2 or 6 times higher rates of deaths.

Conclusion

Elevated plasma PCSK9 level is an independent major predictor of incident CV events and all-cause mortality in black African HD patients.

SUBMITTER: Kajingulu FM 

PROVIDER: S-EPMC8969257 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Circulating Proprotein Convertase Subtilisin/Kexin type 9 level independently predicts incident cardiovascular events and all-cause mortality in hemodialysis black Africans patients.

Kajingulu François-Pantaléon Musungayi FM   Lepira François Bompeka FB   Nkodila Aliocha Natuhoyila AN   Makulo Jean-Robert Rissassy JR   Mokoli Vieux Momeme VM   Ekulu Pepe Mfutu PM   Bukabau Justine Busanga JB   Nlandu Yannick Mayamba YM   Longo Augustin Luzayadio AL   Nseka Nazaire Mangani NM   Labriola Laura L   Sumaili Ernest Kiswaya EK  

BMC nephrology 20220330 1


<h4>Background</h4>Cardiovascular (CV) disease is the leading cause of mortality in patients with end-stage kidney disease (ESKD). The aim of the present study was to determine whether Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9) could be an independent predictor of CV events and all-cause mortality in black African haemodialysis patients.<h4>Methods</h4>We carried out a prospective cohort study of all consecutive hemodialysis (HD) patients between August 2016 and July 2020, admitted in  ...[more]

Similar Datasets

| S-EPMC7316369 | biostudies-literature
| S-EPMC3939022 | biostudies-literature
| S-EPMC5884103 | biostudies-literature
| S-EPMC6383053 | biostudies-literature
| S-EPMC9520287 | biostudies-literature
| S-EPMC3540939 | biostudies-literature
| S-EPMC5746124 | biostudies-literature
| S-EPMC4484737 | biostudies-literature
| S-EPMC6201570 | biostudies-literature
| S-EPMC4363408 | biostudies-literature